Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review.

While the incidence and survival associated with lymphoma have improved in recent years, outcome disparities related to sociodemographic factors such as age, sex, race, ethnicity, socioeconomic status (SES), and other social determinants of health (SDOH) remain prevalent in the modern era. Clinical...

Descripción completa

Detalles Bibliográficos
Publicado en:Oncologist Vol. 30; no. 6; pp. 1 - 11
Autores principales: Jiang, Jun Yang, Li, Ang, Romero, Alexis, Flowers, Christopher R, Nze, Chijioke
Formato: research systematic review tables/charts Journal Article
Publicado: Oxford University Press / USA Jun2025
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=186317272&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 186317272
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        10837159
        IJ7
      jtl: Oncologist
      issn: 10837159
      maglogo: N
    pubinfo:
      dt: Jun2025
      vid: 30
      iid: 6
      pid: 622
      pub: Oxford University Press / USA
    artinfo:
      ui:
        186317272
        186317272
        186317272
        10.1093/oncolo/oyaf180
        186317272
      ppf: 1
      ppct: 10
      formats:
      tig:
        atl: Impact of sociodemographic determinants on enrollment into contemporary lymphoma clinical trials: a systematic review.
      aug:
        au:
          Jiang, Jun Yang
          Li, Ang
          Romero, Alexis
          Flowers, Christopher R
          Nze, Chijioke
        affil: Section of Hematology & Oncology, Department of Medicine, Baylor College of Medicine, Houston, TX, USA
      sug:
        subj:
          Sociodemographic Factors
          Social Determinants of Health
          Research Subject Recruitment
          Lymphoma Therapy
          Clinical Trials United States
          United States
          Human
          Systematic Review
          African Americans
          Hispanic Americans
          Adolescence
          Young Adult
          Economic Status
          Aged
          HIV-Positive Persons
          Cancer Patients
          Housing
          Educational Status
          Employment Status
          Race Factors
          Sex Factors
          Age Factors
          Geographic Factors
          Eligibility Determination
          Checklists
          Adolescent: 13-18 years
          Aged: 65+ years
      ab: While the incidence and survival associated with lymphoma have improved in recent years, outcome disparities related to sociodemographic factors such as age, sex, race, ethnicity, socioeconomic status (SES), and other social determinants of health (SDOH) remain prevalent in the modern era. Clinical trials are crucial for further improving outcomes, yet not all sociodemographic groups are equally represented in contemporary lymphoma trials. We conducted a systematic review of the literature evaluating the impact of SDOH on enrollment into clinical trials in the United States and identified 21 relevant studies. We confirmed that Black and Hispanic individuals are underrepresented in lymphoma clinical trials, due largely to the geographic distribution of clinical trial sites and exacerbated by globalization of cancer trials. Women may also be less appropriately represented than men, although this association is less robust and consistent. Adolescents and young adults with lymphoma who are older, treated at adult cancer centers, or managed by adult hematologists/oncologists are all less likely to be part of trials. Older adults are also excluded from most lymphoma clinical trials. There is a dearth of data on how other SDOHs including education, employment, and household income contribute to differences in clinical trial enrollment. Further research is required to explore the intersection of demographics, SES, insurance status, and enrollment into lymphoma clinical trials.
      pubtype: Academic Journal
      doctype:
        research
        systematic review
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N